Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06499701

Volume Kinetics of Fluid Resuscitation in Early Sepsis

Volume Kinetics of Fluid Resuscitation With 30 ml/kg Ringer Lactate in Early Sepsis

Status
Recruiting
Phase
Study type
Observational
Enrollment
15 (estimated)
Sponsor
Institutul de Urgenţă pentru Boli Cardiovasculare Prof.Dr. C.C. Iliescu · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The recommended volume resuscitation for patients with early sepsis-induced hypoperfusion is at least 30 ml/kg of crystalloid administered within the first three hours. However, this standardized approach does not account for individual patient variability and lacks personalization. Additionally, the effects of administering 30 ml/kg on intercompartmental fluid shifts between the plasma and interstitial compartments remain unclear. This study aims to describe the volume kinetics of administering 30 ml/kg of Ringer's Lactate in patients with early sepsis-induced hypoperfusion within the first three hours.

Detailed description

Adult patients admitted to the intensive care unit (ICU) with sepsis, as defined by the Sepsis-3 criteria, and exhibiting sepsis-induced hypoperfusion prior to receiving adequate volume resuscitation (i.e., 30 ml/kg of crystalloid), are administered Ringer's Lactate at a dose of 30 ml/kg. The initial 20 ml/kg is infused at a constant rate over the first 30 minutes, followed by a 30-minute pause, with an additional 10 ml/kg administered over the subsequent 15 minutes, completing the infusion within 75 minutes. Up to 180 minutes post-infusion, no other fluids (e.g., gelatin, albumin) are administered except for antibiotics, sedatives, or vasoactive substances as needed. Ideally, only one catecholamine (e.g., norepinephrine) is administered. The volume and quantity of these substances are recorded. Arterial blood samples are collected for blood gas analysis, including hemoglobin levels. Urinary output is measured at 30, 60, and 180 minutes, and any blood loss, other than the 1.5 ml per sample collected, is quantified during hemoglobin monitoring. Additionally, urinary creatinine concentration is determined from urine samples collected at baseline. The hemodilution data are utilized as input into a three-compartment model with microconstants for fluid redistribution and excretion.

Conditions

Interventions

TypeNameDescription
DRUGRinger's LactateRinger's Lactate is administered at a dose of 30ml/kg, with the first 20ml/kg given at a constant rate over the initial 30 minutes, followed by a 30-minute pause, and then an additional 10ml/kg over the next 15 minutes, completing the infusion within 75 minutes.

Timeline

Start date
2024-06-19
Primary completion
2026-07-01
Completion
2026-07-30
First posted
2024-07-12
Last updated
2026-03-18

Locations

2 sites across 1 country: Romania

Regulatory

Source: ClinicalTrials.gov record NCT06499701. Inclusion in this directory is not an endorsement.